NuvOx Makes the Transition from the Laboratory to the Clinic and is Pounding the Pavement to Raise $15MM

NuvOx Pharma, a Tucson-based biotech startup, founded in 2008 is metamorphosing from an R&D startup to one that is testing the Company’s nanotechnology therapeutic platform in the clinic.

According to Chief Business Officer, David Wilson, this transition ratchets up the expenses, but clinical trials are the only way to determine the therapeutic potential of the NuvOx platform and to garner the interest of potential collaborators and investors. “With demonstrated proof-of-concept in humans, we are now ready to start discussions with potential corporate partners and institutional investors”, according to Dr. Wilson.

Read more: NuvOx Makes the Transition from the Laboratory to the Clinic and is Pounding the Pavement to Raise $15MM